These results obtained in both MEL202 and 92.1 uveal melanoma cells suggest that indeed the oncogenic function of MDMX is not only the attenuation of p53 tumor suppressor activity but also by diminution of a tumor suppressor function of FOXO transcription factors. This evidence concerns the gene TP53 and neoplasm.